Live Breaking News & Updates on Advance Novel Pain Therapies

Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by. ....

United States , Sameer Sabir , Brixton Biosciences , Michael Fishman , Sv Health Investors , Catalyst Health Ventures , Sparta Group , Centric Pain Solutions , Brixton Biosciences Secures , Advance Novel Pain Therapies , Chief Executive Officer , Should Know , Schooner Capital , Excelestar Ventures , Catalyst Health , Chief Medical , Reggie Groves , Pioneering Patient Centric Pain , Massachusetts General Brigham , Neural Ice , Biosciences Secures , Breakthrough Device Designation ,